Trump nominates Casey Means as Surgeon General to overhaul U.S. healthcare

The White House announced the nomination of Casey Means, a physician and advocate for holistic medicine, as the new U.S. Surgeon General. Unveiled on May 7, 2025, the decision underscores President Trump’s focus on addressing the nation’s public health crisis, particularly chronic diseases and the restructuring of the medical system. Means, known for her outspoken criticism of the pharmaceutical industry and conventional medical practices, steps into the role amid heated debates over healthcare policy. Her nomination has already sparked polarized reactions in Congress and the medical community.

The announcement follows the withdrawal of the previous nominee, Janette Nesheiwat, whose confirmation hearing was scheduled for the same day. Means, a prominent figure in the “Make America Healthy Again” (MAHA) movement led by Robert F. Kennedy Jr., pledges to prioritize disease prevention and reduce reliance on pharmaceutical interventions. The nomination was revealed during a White House event, where Trump emphasized the need to “revolutionize American healthcare.”

A Stanford-educated physician, Means has positioned herself as a critic of what she calls a “corrupted healthcare system.” Her speeches highlight the prevalence of chronic diseases among children and adults, attributing the issue to factors like processed foods, environmental toxins, and a medical system focused on treatment rather than prevention. The selection of Means signals a shift in public health strategy, aligning with Trump’s 2025 campaign promises.

• Key points of the nomination:
  • Casey Means replaces Janette Nesheiwat, who was withdrawn from consideration.
  • Emphasis on preventing chronic diseases and critiquing pharmaceutical influence.
  • Backed by Robert F. Kennedy Jr. and the MAHA movement.
  • Confirmation hinges on a Senate Health Committee hearing.

Congressional reactions

The nomination of Casey Means as Surgeon General triggered immediate responses on Capitol Hill. Republican senators, such as Rand Paul, praised the choice, underscoring the need for a fresh perspective in public health. Paul, a longtime advocate for medical system reforms, stated that Means could provide “the outsider vision needed to challenge entrenched interests.” Senator Susan Collins, however, expressed caution, calling for a thorough review of Means’ proposals during the confirmation process.

Democrats were more critical. Senator Tammy Baldwin, who recently challenged Health Secretary Robert F. Kennedy Jr. over cuts to mental health services, questioned Means’ qualifications for the role. Baldwin stressed that the Surgeon General must ground recommendations in robust scientific evidence, a standard she believes Means has yet to meet. Senator Elizabeth Warren also raised concerns, citing Means’ history of criticizing conventional medicine as potentially divisive.

The confirmation hearing, yet to be scheduled, will be overseen by the Senate Health, Education, Labor, and Pensions (HELP) Committee. Chaired by Senator Bill Cassidy, the committee has indicated that Means’ nomination will face close scrutiny, particularly regarding her views on vaccines and pharmaceuticals. Cassidy, who recently criticized Kennedy Jr.’s decision to end federal water fluoridation recommendations, vowed to ensure a “rigorous and fair” process.

• Issues raised in the Senate:
  • Scientific credibility of Means’ proposals.
  • Alignment with evidence-based healthcare policies.
  • Potential impact of her pharmaceutical critiques on public policy.

Casey Means’ background

Casey Means, 37, is an emerging voice in the U.S. public health debate. Trained as an otolaryngology surgeon at Stanford University, she initially practiced clinical medicine before shifting to advocacy for healthcare reform. Her transition was driven by personal and professional experiences, including her belief that the medical system prioritizes profitable treatments over prevention.

Means gained prominence through articles and podcast appearances, where she criticized the influence of the pharmaceutical and processed food industries on American health. In a widely shared 2024 video, she claimed that “half of American children suffer from chronic diseases,” citing federal studies showing rising rates of obesity, type 2 diabetes, and autoimmune disorders. Her approach, blending medical science with social critique, has attracted both supporters and skeptics.

Alongside her brother, Calley Means, Casey co-founded Levels Health, a company focused on metabolic monitoring to prevent chronic diseases. The platform, which uses wearable technology to track glucose levels, reflects her vision of individualized healthcare. Her collaboration with Robert F. Kennedy Jr. in the MAHA movement further solidified her role as a leader in efforts to curb lifestyle-related illnesses.

Public health landscape in 2025

Means’ nomination comes at a pivotal moment for U.S. public health. Recent data from the Centers for Disease Control and Prevention (CDC) show that 60% of American adults live with at least one chronic condition, such as hypertension, diabetes, or heart disease. Among children, obesity rates have tripled over the past four decades, reaching 20% in 2024. These figures fuel debates over the effectiveness of the current healthcare system.

The Trump administration, in its second term, has prioritized structural changes in the sector. In January 2025, the president signed executive orders restricting funding for “gain-of-function” research and promoting drug pricing policies based on international benchmarks. Means’ nomination, coupled with Kennedy Jr.’s appointment as Health Secretary, suggests an agenda blending skepticism of traditional medicine with a focus on prevention and wellness.

The nomination also reflects the growing influence of movements like MAHA, which advocates for reducing environmental toxins, revising nutritional guidelines, and increasing transparency in the pharmaceutical industry. In a March 2025 speech, Kennedy Jr. announced plans to review CDC vaccine guidelines, a proposal Means publicly supported. This stance drew criticism from medical associations, such as the American Medical Association (AMA), which warned against politicizing science.

Ver essa foto no Instagram

Uma publicação compartilhada por President Donald J. Trump (@realdonaldtrump)

Chronic disease crisis

Casey Means’ focus on the chronic disease crisis resonates with a growing audience but also faces pushback. She notes that chronic disease costs account for roughly 75% of annual U.S. healthcare spending, totaling over $3 trillion in 2024. These figures, supported by Department of Health and Human Services (HHS) reports, highlight the urgency of addressing factors like diet, stress, and chemical exposure.

Means argues that the current system incentivizes reactive treatments, such as drug prescriptions, over preventive measures. At an April 2025 event, she cited a 30% rise in type 2 diabetes diagnoses among teens between 2010 and 2020 as evidence of systemic failures. Her proposals include reforming school lunch programs, regulating chemical additives in food, and promoting metabolic health education.

• Factors emphasized by Means:
  • Childhood obesity rates reached 20% in 2024.
  • Chronic disease costs hit $3 trillion annually.
  • Lack of regulation on additives in processed foods.
  • Need for educational programs on preventive health.

Pharmaceutical industry critiques

A cornerstone of Casey Means’ platform is her critique of the pharmaceutical industry’s influence. She claims companies prioritize profits over health, promoting drugs that address symptoms without tackling root causes. In a 2024 social media video, Means stated that “children receive pharmaceutical interventions hours after birth,” referring to practices like vaccine administration and hospital medications.

This rhetoric has garnered support from anti-vaccine movements, though Means has avoided directly endorsing such views. Instead, she advocates for greater transparency on drug and vaccine effects, as well as independent safety studies. The American Academy of Pediatrics (AAP) responded, warning that such statements could undermine trust in immunization programs that have saved millions of lives.

Means’ nomination aligns with the Trump administration’s efforts to lower drug prices. In May 2025, the White House proposed an international pricing policy, tying U.S. drug costs to those in other countries. Means endorsed the measure but suggested that long-term solutions lie in reducing drug dependency through lifestyle changes.

Role of the Surgeon General

The Surgeon General’s role, while advisory, carries significant weight in shaping public health policy. The office is responsible for issuing reports, leading awareness campaigns, and advising the government on health matters. During the COVID-19 pandemic, former Surgeon General Jerome Adams played a key role in communicating federal guidelines.

If confirmed, Casey Means will face a broad range of issues, from the opioid crisis to mental health. Her nomination suggests the Trump administration aims to leverage the role to advance a prevention-focused agenda and challenge the medical establishment. In a 2024 speech, Means vowed to “amplify the voices of patients and doctors questioning the status quo.”

The previous Surgeon General, Vivek Murthy, focused on combating health misinformation and promoting equitable access to care. Means’ appointment marks a shift toward alternative approaches and systemic critiques. Her confirmation will depend on her ability to convince senators of the feasibility and scientific grounding of her ideas.

• Responsibilities of the role:
  • Issuing public health reports.
  • Leading national awareness campaigns.
  • Advising the president and Health Secretary.
  • Communicating with the public during health crises.

Influence of the MAHA movement

The “Make America Healthy Again” (MAHA) movement, spearheaded by Robert F. Kennedy Jr., has been instrumental in Casey Means’ rise. Launched in 2024, MAHA seeks to reform healthcare through three pillars: disease prevention, industry transparency, and environmental toxin reduction. Means, a key spokesperson, has participated in national events to promote these goals.

At a March 2025 rally in New York, Means called for revising federal nutritional guidelines, which she claims prioritize food industry interests over public health. MAHA also proposes an independent council to evaluate vaccine safety, a controversial idea among scientists and physicians.

Kennedy Jr.’s support for Means’ nomination underscores MAHA’s influence in the Trump administration. In a social media post, Kennedy Jr. described Means as “a warrior for true health.” The partnership raises questions about the extent to which MAHA’s ideas will shape federal health policies.

Confirmation challenges

Casey Means’ Senate confirmation hearing will be a critical hurdle. The HELP Committee, with members from both parties, has a history of rigorously questioning nominees on controversial issues. In 2021, Rachel Levine’s confirmation as Assistant Health Secretary faced opposition over gender policy debates.

Means is likely to face scrutiny over her pharmaceutical critiques and vaccine stance. Senator Bernie Sanders, a committee member, has expressed concern about what he calls the “politicization of public health” under Trump. Sanders emphasized the need for leaders who prioritize scientific evidence over populist narratives.

The withdrawal of Janette Nesheiwat, the prior nominee, adds pressure on Means to secure bipartisan support. Nesheiwat, a physician with emergency medicine experience, was withdrawn without public explanation, fueling speculation about internal administration divisions. Means must demonstrate that her vision is practical and can bridge party lines.

• Key confirmation issues:
  • Stance on vaccines and immunization programs.
  • Proposals to address chronic disease costs.
  • Response to medical association criticisms.
  • Ability to articulate a practical vision for the role.

Medical community responses

Casey Means’ nomination has divided the medical community. The American Medical Association (AMA) issued a statement urging the Surgeon General to base recommendations on “robust data and scientific consensus.” The AMA emphasized the importance of maintaining public trust in programs like vaccination and disease screening.

Conversely, integrative medicine practitioners and functional medicine advocates praised the choice. The American Association of Integrative Medicine (AAIM) released a statement commending Means for her “courage in challenging the system.” The AAIM argues that her nomination reflects growing demand for holistic health approaches.

Hospitals and clinics are also monitoring the nomination closely. In May 2025, the American Hospital Association (AHA) warned that federal policies, such as tariffs on imported drugs, could raise care costs. The AHA hopes Means, if confirmed, will prioritize access to essential treatments.

Political landscape in 2025

Means’ nomination unfolds amid intense political maneuvering in Washington. The Trump administration, which began its second term in January 2025, faces pressure to deliver on campaign promises like lowering drug prices and reforming Medicaid. Means’ selection is seen as part of a strategy to solidify support among voters skeptical of the medical establishment.

Republicans control both the House and Senate, but internal divisions complicate major reforms. In May 2025, Senate Republicans plan a retreat to discuss the reconciliation agenda, including healthcare changes. Means’ nomination could influence these talks, particularly if she gains traction for her prevention-focused proposals.

Democrats plan to use the confirmation hearing to highlight differences with the Trump administration. Senator Patty Murray, former HELP Committee chair, stated that public health “cannot be held hostage to unproven theories.” The Democratic opposition will likely focus on Means’ credentials and ties to controversial figures like Kennedy Jr.

• Political factors at play:
  • Republican control of Congress aids nominations.
  • Internal GOP divisions over healthcare reforms.
  • Democratic strategy to challenge nominee credentials.
  • Public demand for healthcare system changes.